Novastan argatroban small molecule thrombin inhibitor data

In a Phase III trial of Novastan as an anticoagulant in patients with a history of allergic reaction to heparin, all 30 patients met the primary end point of completing the surgical procedure (either angioplasty, atherectomy, or stent placement). One patient experienced significant bleeding as a side effect. ...